Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Arbutus Biopharma Corp changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 112 | +14 |
| Shares | 70.8M | 10.0K | 79.0M | +8.12M (+11.5%) |
| Value | $143.8M | $20.3K | $197.4M | +$53.6M (+37.3%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Arbutus Biopharma Corp at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 3,468,824 | $8.67M | 3.88% |
| Ledgewood Wealth Advisors, LLC | 278,436 | $696.1K | 0.64% |
| Point72 Asset Management, L.P. | 105,000 | $262.5K | 0.00% |
| Jane Street Group, LLC | 96,509 | $241.3K | 0.00% |
| Cowen and Company, LLC | 50,000 | $125.0K | 0.01% |
| National Philanthropic Trust | 37,688 | $94.2K | 0.00% |
| GTS Securities LLC | 31,440 | $78.6K | 0.00% |
| Two Sigma Advisers, LP | 31,000 | $77.5K | 0.00% |
| Premier Path Wealth Partners, LLC | 22,200 | $55.5K | 0.01% |
| Virtu Financial LLC | 17,923 | $45.0K | 0.00% |
| Brevan Howard Capital Management LP | 17,759 | $44.4K | 0.00% |
| Creative Planning | 14,566 | $36.4K | 0.00% |
| Pathstone Holdings, LLC | 10,155 | $25.4K | 0.00% |
| Group One Trading, L.P. | 7,312 | $18.3K | 0.00% |
| Cubist Systematic Strategies, LLC | 7,192 | $18.0K | 0.00% |
| DAGCO, Inc. | 6,300 | $15.8K | 0.01% |
| Dynamic Wealth Strategies, LLC | 6,300 | $15.8K | 0.01% |
| Lindbrook Capital, LLC | 284 | $710 | 0.00% |
| Private Wealth Management Group, LLC | 242 | $605 | 0.00% |
| The PNC Financial Services Group, Inc. | 208 | $520 | 0.00% |
| GAMMA Investing LLC | 187 | $443 | 0.00% |
Sold out (7)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Jefferies Financial Group Inc. | 264,441 | $536.8K |
| Kepos Capital LP | 155,691 | $316.0K |
| Ameriprise Financial Inc | 98,000 | $198.9K |
| AQR Capital Management LLC | 40,598 | $82.4K |
| Virtus ETF Advisers LLC | 40,040 | $81.3K |
| Victory Capital Management Inc | 13,810 | $28.0K |
| US Bancorp | 1,909 | $3.88K |
Not filed for Q4 2023 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Pathstone Family Office, LLC | 10,000 | $20.3K |